Union Hospital, Fujian Medical University,, Fuzhou (China)
Follow
Contributor content
Presentation
Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study
